We are live on ! Find out more
VMD icon

Viemed Healthcare

104 hedge funds and large institutions have $184M invested in Viemed Healthcare in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 37 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more call options, than puts

Call options by funds: $12K | Put options by funds: $5K

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

16% more capital invested

Capital invested by funds: $159M → $184M (+$25.6M)

0.34% less ownership

Funds ownership: 61.31%60.97% (-0.34%)

7% less funds holding

Funds holding: 112104 (-8)

16% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 37

40% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 20

Holders
104
Holders Change
-8
Holders Change %
-7.14%
% of All Funds
1.52%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
12
Increased
31
Reduced
37
Closed
20
Calls
$12K
Puts
$5K
Net Calls
+$7K
Net Calls Change
+$3K
Name Holding Trade Value Shares
Change
Change in
Stake
Thrivent Financial for Lutherans
1
Thrivent Financial for Lutherans
Minnesota
$26.3M -$362K -49,903 -1%
BlackRock
2
BlackRock
New York
$16.7M +$1.04M +143,490 +7%
NCM
3
Nantahala Capital Management
Connecticut
$15.3M -$579K -79,802 -4%
FCM
4
Forager Capital Management
Alabama
$13.5M -$176K -24,306 -1%
AIC
5
AWM Investment Company
New York
$11.2M +$1.68M +231,120 +19%
Vanguard Group
6
Vanguard Group
Pennsylvania
$9.14M +$105K +14,484 +1%
WA
7
Wasatch Advisors
Utah
$9.13M
CSC
8
Cove Street Capital
California
$7.23M -$169K -23,350 -2%
HIM
9
Hillsdale Investment Management
Ontario, Canada
$6.03M -$1.37M -188,556 -20%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$5.29M -$942K -129,789 -16%
PAIM
11
Punch & Associates Investment Management
Minnesota
$5.25M +$1.15M +158,832 +31%
Morgan Stanley
12
Morgan Stanley
New York
$4.93M +$2.45M +337,589 +116%
State Street
13
State Street
Massachusetts
$3.61M +$142K +19,550 +4%
TAM
14
Tocqueville Asset Management
New York
$3.2M +$80.5K +11,100 +3%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$2.98M +$89.5K +12,330 +3%
RA
16
Raffles Associates
New York
$2.73M +$249K +34,313 +11%
BA
17
Bard Associates
Illinois
$2.66M +$2.2M +303,880 +882%
PCMI
18
Paradigm Capital Management Inc
New York
$2.51M
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$2.51M -$17.5K -2,406 -0.7%
Renaissance Technologies
20
Renaissance Technologies
New York
$2.23M -$310K -42,700 -13%
Goldman Sachs
21
Goldman Sachs
New York
$1.97M +$43K +5,929 +2%
EIM
22
Essex Investment Management
Massachusetts
$1.93M -$126K -17,399 -7%
Northern Trust
23
Northern Trust
Illinois
$1.79M -$29.4K -4,055 -2%
LPL Financial
24
LPL Financial
California
$1.47M +$21K +2,900 +2%
MAG
25
Millrace Asset Group
Pennsylvania
$1.46M +$1.35M +185,679 New

VMD Hedge Fund Activity: Q4 2023 in Review

104 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q4 2023, worth a combined $184M — up 16% from $159M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of VMD and 12 opened new positions — a net loss of 8 holders — while 37 trimmed existing stakes and 31 added.

The largest buyer was Morgan Stanley, adding an estimated $2.45M. The largest seller was Connor, Clark & Lunn Investment Management (CC&L), cutting an estimated $2.31M.

  • 104 institutional investors held Viemed Healthcare (VMD) as of Q4 2023, down from 112 in Q3 2023.
  • Funds reported $184M of Viemed Healthcare stock for Q4 2023, up 16% quarter-over-quarter.
  • 12 funds opened new Viemed Healthcare positions in Q4 2023 and 20 closed out, a net change of -8 holders.
  • The largest Viemed Healthcare buyer in Q4 2023 was Morgan Stanley, an estimated $2.45M added.
  • The largest Viemed Healthcare seller in Q4 2023 was Connor, Clark & Lunn Investment Management (CC&L), an estimated $2.31M sold.

Based on aggregated 13F filings for Q4 2023.